{"DataElement":{"publicId":"14758298","version":"1","preferredName":"Clinical Study Prior Taxane Compound Personal Medical History Stratification Factors Indicator Code","preferredDefinition":"The coded yes/no indicator whether there was prior use of a taxane compound in person medical history as a pre-treatment factor by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"3303243v1.00:3025013v1.00","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3303243","version":"1","preferredName":"Clinical Study Prior Taxane Compound Personal Medical History Stratification Factors","preferredDefinition":"information related to prior use of a taxane compound (a type of drug that blocks cell growth by stopping mitosis (cell division), interfere with microtubules (cellular structures that help move chromosomes during mitosis), and are used to treat cancer), as part of a person medical history, an account of all medical events and problems a person has experienced, as a pre-treatment factor by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"2430995v1.0:3303241v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2430995","version":"1","preferredName":"Study","preferredDefinition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical trial.","longName":"C15206","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05D7809E-DF10-22B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-18","modifiedBy":"ONEDATA","dateModified":"2005-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3303241","version":"1","preferredName":"Prior Taxane Compound Personal Medical History Stratification Factors","preferredDefinition":"Earlier in time or order.:Anticancer drugs that inhibit cancer cell growth by stopping cell division. Also called antimitotic or antimicrotubule agents or mitotic inhibitors.:an account of all medical events and problems a person has experienced.:Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"C25629:C1490:C18772:C16153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Taxane Compound","conceptCode":"C1490","definition":"A type of drug that blocks cell growth by stopping mitosis (cell division). Taxanes interfere with microtubules (cellular structures that help move chromosomes during mitosis). They are used to treat cancer. A taxane is a type of mitotic inhibitor and a type of antimicrotubule agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Personal Medical History","conceptCode":"C18772","definition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification Factors","conceptCode":"C16153","definition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B8B0DE-105B-EEFC-E040-BB89AD431883","latestVersionIndicator":"Yes","beginDate":"2011-11-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-14","modifiedBy":"ONEDATA","dateModified":"2011-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B8B0DE-106C-EEFC-E040-BB89AD431883","latestVersionIndicator":"Yes","beginDate":"2011-11-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3025013","version":"1","preferredName":"Indicator Code","preferredDefinition":"A response or indicator that can have a value of either yes or no.","longName":"3025013v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"2","valueDescription":"No ","ValueMeaning":{"publicId":"2567170","version":"1","preferredName":"No","longName":"2567170","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":"Updated to add NCIt concept relationship. Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81DABEB5-E552-E8D2-E040-BB89AD433774","beginDate":"2010-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-03-15","modifiedBy":"ONEDATA","dateModified":"2010-03-15","deletedIndicator":"No"},{"value":"1","valueDescription":"Yes","ValueMeaning":{"publicId":"2567168","version":"1","preferredName":"Yes","longName":"2567168","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":"12/29/2006 - Updated with NCI Thesaurus definition.","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81DABEB5-E55C-E8D2-E040-BB89AD433774","beginDate":"2010-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-03-15","modifiedBy":"ONEDATA","dateModified":"2010-03-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DA91FB-CAD2-1B0D-E040-BB89AD4301BE","latestVersionIndicator":"Yes","beginDate":"2010-03-15","endDate":null,"createdBy":"UMLLOADER_HINTSPRD","dateCreated":"2010-03-15","modifiedBy":"REEVESD","dateModified":"2014-08-17","changeDescription":"Modified to meet best practice criteria. Released as part of UML model cleanup. mc 10/31/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Prior taxane","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"114BFB49-C9D5-4EF2-E063-731AD00AF914","latestVersionIndicator":"Yes","beginDate":"2024-02-13","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2024-02-13","modifiedBy":"ZHWENDY","dateModified":"2024-02-14","changeDescription":null,"administrativeNotes":"2/14/24 Created for CTEP stratification questions.  Duplicate of old CDE 3303245 that had a retired VD. wz","unresolvedIssues":null,"deletedIndicator":"No"}}